1
190
S. Hu et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 136 (2015) 1188–1194
Table 1
Crystal structure data and structure refinement for 1.
literature [33]. A mixture of pyrazoline (4) (0.37 g, 1 mmol), ethyl
bromoacetate (0.20 g, 1.2 mmol), KI (0.17 g, 1 mmol), CO
K
2
3
Empirical formula
Formula weight
Temperature
Wavelength (Å)
Crystal system
Space group
a (Å)
b (Å)
c (Å)
a
C
26
H
23
3
N O
3
S
(0.33 g, 2.4 mmol), and acetone (25 ml) was stirred at reflux for
2 h. After cooling, the mixture was filtered and the filtrate was
evaporated to afford residue. The residue was crystallized from
457.53
298(2) K
0.71073
Monoclinic
C2/c
24.516(4)
9.1979(13)
20.561(3)
90°
101.315(2) °
90°
3669.9(6)
8
ethanol to afford 1 (0.27 g) as a white solid, Yield: 60%; Mp:
ꢂ1
1
43–144 °C;IR (KBr, cm ): 3423, 2920, 2359, 1752, 1597, 1540,
1
1444, 1320, 1280, 1210, 1124, 1083, 809, 754; H NMR (300 MHz,
CDCl ): d8.07–8.10 (m, 1H), 7.61–7.63 (m, 1H), 7.49–7.51 (m, 1H),
.20–7.37 (m, 8H), 7.06–7.10 (m, 2H), 6.77–6.80 (m, 1H), 5.78
dd, 1H, J = 4.5, 4.5 Hz, pyrazoline-H), 1.23 (t, 3H, CH3-H); 4.62
(s, 2H); 4.18–4.29 (m, 3H), 3.58 (dd, 1H, J = 4.5, 4.5 Hz, pyrazoline-
3
7
(
b
c
3
13
V (Å )
H), 1.23 (t, 3H, CH3AH);
C NMR (75 MHz, CDCl
63.5,155.9, 152.6, 141.5, 131.7, 131.3, 129.6, 128.8, 127.6, 126.0,
25.6, 122.0, 119.9, 112.3, 65.5, 63.8, 61.5, 47.0, 14.1; ESI-MS: m/
3
): 168.2,
Z
1
1
3
Density (calculated)
Index ranges
F(000)
1.337 Mg/m
ꢂ35 6 h 6 35, ꢂ12 6 k 6 13, ꢂ29 6 l 6 29
+
z: 458.7 [M + H] . Anal. calcd for C26
9.18; found: C 68.22, H 5.04, N 9.14.
23 3 3
H N O S: C 68.25, H 5.07, N
1616
Crystal size
0.15 ꢃ 0.12 ꢃ 0.10 mm
1.69–30.99°
24263
7184 [R(int) = 0.1222]
0.9826 and 0.9740
7184/0/300
h range for data collection
Reflections collected
Independent reflections
Max. and min. transmission
Data/restraints/parameters
Goodness-of-fit on F2
Absorption correction
Final R indices (I > 2
R indices (all data)
Largest diff. peak and hole
X-ray crystallography of compound 1
Suitable single crystals of 1 for X-ray structural analysis were
obtained by slow evaporation of a solution of 1 in CHCl ACH OH
20:1, v/v) mixture at room temperature. The diffraction data
was collected with a Bruker SMART CCD diffractometer using a
graphite monochromated MoK radiation (k = 0.71073 Å) at
96(2)K. The structures were solved by direct methods with SHEL-
0.842
None
3
3
(
r(I))
R1 = 0.0519, wR2 = 0.1026
R1 = 0.1228, wR2 = 0.1270
0.245 and ꢂ0.369 e Å
ꢂ3
a
2
2
XS-97 program and refinements on F were performed with SHEL-
XL-97 program by full-matrix least-squares techniques with
anisotropic thermal parameters for the non-hydrogen atoms. All
H atoms were initially located in a difference Fourier map. All H
atoms were placed in geometrically idealized positions and con-
strained to ride on their parent atoms, with CAH = 0.93 Å and
spectra were recorded on a Perkin-Elmer PE-983 infrared spec-
trometer as KBr pellets with absorption reported in cm . Absorp-
tion spectra were determined on UV-2501 PC spectrophotometer.
Fluorescence spectra measurements were performed on a Fluoro-
Max-P spectrofluorimeter equipped with a xenon discharge lamp,
ꢂ1
Uiso(H) = 1.2 Ueq(C).
1
cm quartz cells at room temperature (about 298 K).
Synthesis of ethyl 2-(2-(1-(benzo[d]thiazol-2-yl)-4-phenyl-4,5-
Binding titration
dihydro-1H-pyrazol-3-yl)phenoxy)acetate (1)
ꢂ5
The stock solutions of 1 (1.0 ꢃ 10 M) were prepared by
dissolving in MeOH/water(95:5, v/v) containing HEPES
buffer(10 mM, pH = 7.0). The cationic stocks were all in MeOH with
The synthetic route of the compound 1 is shown in Scheme 1.
Starting material pyrazoline (4) was synthesized according to
1
Fig. 2. A packing diagram for 1, viewed along the c-axis.